Novavax Gets FDA's Fast Track Designation For Its RSV Vaccine For Older Adults
May 25, 2016 at 09:09 AM EDT
Novavax, Inc. (NASDAQ: NVAX), a clinical-stage vaccine company, revealed Wednesday that the U.S. Food and Drug Administration has ...